Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.

Mehra V, Rhone E, Widya S, Zuckerman M, Potter V, Raj K, Kulasekararaj A, McLornan D, de Lavallade H, Benson-Quarm N, Lim C, Ware S, Sudhanva M, Malik O, Nicholas R, Muraro PA, Marsh J, Mufti GJ, Silber E, Pagliuca A, Kazmi MA.

Clin Infect Dis. 2019 Jan 15. pii: ciz047. doi: 10.1093/cid/ciz047. [Epub ahead of print]

PMID:
30980715
2.

'It's the unknown' - understanding anxiety: from the perspective of people with multiple sclerosis.

Butler E, Thomas R, Carolan A, Silber E, Chalder T.

Psychol Health. 2019 Mar;34(3):368-383. doi: 10.1080/08870446.2018.1541989. Epub 2018 Dec 27.

PMID:
30588838
3.

Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis.

Reen GK, Silber E, Langdon DW.

Value Health. 2018 Jul;21(7):762-766. doi: 10.1016/j.jval.2017.12.015. Epub 2018 Feb 9.

PMID:
30005747
4.

Letter to the Editor: NMDA receptor autoimmunity in mania following HSV encephalitis.

Blackman G, Moran N, Silber E, Symeon C, Brunnhuber F, Mazumder A, Jaffer F, Pollak T.

Psychol Med. 2018 May;48(7):1221-1223. doi: 10.1017/S0033291718000053. Epub 2018 Feb 14. No abstract available.

PMID:
29439749
5.

Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy.

Rhone EE, Cho PSP, Birring SS, Galloway J, Silber E.

Mult Scler Relat Disord. 2018 Feb;20:25-27. doi: 10.1016/j.msard.2017.12.011. Epub 2017 Dec 18.

PMID:
29276998
6.

Neurogenic pulmonary oedema: a rare cause of maternal collapse.

Farooq H, Veerareddy S, Silber E.

BMJ Case Rep. 2017 Jun 26;2017. pii: bcr2016217375. doi: 10.1136/bcr-2016-217375.

PMID:
28652270
7.

Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review.

Reen GK, Silber E, Langdon DW.

J Neurol Sci. 2017 Apr 15;375:107-122. doi: 10.1016/j.jns.2016.12.038. Epub 2016 Dec 23. Review.

PMID:
28320112
8.

The spectrum of psychosis in multiple sclerosis: a clinical case series.

Gilberthorpe TG, O'Connell KE, Carolan A, Silber E, Brex PA, Sibtain NA, David AS.

Neuropsychiatr Dis Treat. 2017 Feb 1;13:303-318. doi: 10.2147/NDT.S116772. eCollection 2017.

9.

Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review.

Reen GK, Silber E, Langdon DW.

Patient Educ Couns. 2017 Jun;100(6):1031-1048. doi: 10.1016/j.pec.2016.12.028. Epub 2016 Dec 28. Review.

PMID:
28108125
10.

Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.

Gao W, Crosby V, Wilcock A, Burman R, Silber E, Hepgul N, Chaudhuri KR, Higginson IJ; OPTCARE Neuro trial.

PLoS One. 2016 Oct 25;11(10):e0165379. doi: 10.1371/journal.pone.0165379. eCollection 2016.

11.

Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis.

Bogosian A, Hughes A, Norton S, Silber E, Moss-Morris R.

Br J Health Psychol. 2016 Nov;21(4):859-880. doi: 10.1111/bjhp.12201.

PMID:
27238732
12.

How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.

van Vliet LM, Gao W, DiFrancesco D, Crosby V, Wilcock A, Byrne A, Al-Chalabi A, Chaudhuri KR, Evans C, Silber E, Young C, Malik F, Quibell R, Higginson IJ; OPTCARE Neuro.

BMC Neurol. 2016 May 10;16:63. doi: 10.1186/s12883-016-0583-6.

13.

The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.

Hayter AL, Salkovskis PM, Silber E, Morris RG.

Br J Clin Psychol. 2016 Nov;55(4):371-386. doi: 10.1111/bjc.12106. Epub 2016 Jan 25.

PMID:
26806805
14.

Beyond a physical symptom: the importance of psychosocial factors in multiple sclerosis pain.

Harrison AM, Silber E, McCracken LM, Moss-Morris R.

Eur J Neurol. 2015 Nov;22(11):1443-52. doi: 10.1111/ene.12763. Epub 2015 Jul 14.

PMID:
26177836
15.

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.

Scolding N, Barnes D, Cader S, Chataway J, Chaudhuri A, Coles A, Giovannoni G, Miller D, Rashid W, Schmierer K, Shehu A, Silber E, Young C, Zajicek J.

Pract Neurol. 2015 Aug;15(4):273-9. doi: 10.1136/practneurol-2015-001139. Epub 2015 Jun 22. No abstract available.

PMID:
26101071
16.

Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.

Koffman J, Goddard C, Gao W, Jackson D, Shaw P, Burman R, Higginson IJ, Silber E.

BMC Palliat Care. 2015 Apr 19;14:13. doi: 10.1186/s12904-015-0017-z.

17.

Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.

Tully T, Barkley A, Silber E.

Neurology. 2015 May 12;84(19):1999-2001. doi: 10.1212/WNL.0000000000001556. Epub 2015 Apr 15. No abstract available.

PMID:
25878178
18.

Distress improves after mindfulness training for progressive MS: A pilot randomised trial.

Bogosian A, Chadwick P, Windgassen S, Norton S, McCrone P, Mosweu I, Silber E, Moss-Morris R.

Mult Scler. 2015 Aug;21(9):1184-94. doi: 10.1177/1352458515576261. Epub 2015 Mar 12.

PMID:
25767124
19.

Survey on Addressing the Information and Support Needs of Jewish Women at Increased Risk for or Diagnosed with Breast Cancer: The Sharsheret Experience.

Tercyak KP, Silber E, Johnson AC, Fleischmann A, Murphy SE, Mays D, O'Neill SC, Sharkey CM, Shoretz R.

Healthcare (Basel). 2015 May 22;3(2):324-37. doi: 10.3390/healthcare3020324.

20.

'It feels like someone is hammering my feet': understanding pain and its management from the perspective of people with multiple sclerosis.

Harrison AM, Bogosian A, Silber E, McCracken LM, Moss-Morris R.

Mult Scler. 2015 Apr;21(4):466-76. doi: 10.1177/1352458514544538. Epub 2014 Aug 11.

PMID:
25112815
21.

Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.

Smith W, McCrone P, Goddard C, Gao W, Burman R, Jackson D, Higginson I, Silber E, Koffman J.

Mult Scler Int. 2014;2014:613701. doi: 10.1155/2014/613701. Epub 2014 Feb 5.

22.

A 500-kiloton airburst over Chelyabinsk and an enhanced hazard from small impactors.

Brown PG, Assink JD, Astiz L, Blaauw R, Boslough MB, Borovička J, Brachet N, Brown D, Campbell-Brown M, Ceranna L, Cooke W, de Groot-Hedlin C, Drob DP, Edwards W, Evers LG, Garces M, Gill J, Hedlin M, Kingery A, Laske G, Le Pichon A, Mialle P, Moser DE, Saffer A, Silber E, Smets P, Spalding RE, Spurný P, Tagliaferri E, Uren D, Weryk RJ, Whitaker R, Krzeminski Z.

Nature. 2013 Nov 14;503(7475):238-41. doi: 10.1038/nature12741. Epub 2013 Nov 6.

PMID:
24196713
23.

Progression, symptoms and psychosocial concerns among those severely affected by multiple sclerosis: a mixed-methods cross-sectional study of Black Caribbean and White British people.

Koffman J, Gao W, Goddard C, Burman R, Jackson D, Shaw P, Barnes F, Silber E, Higginson IJ.

PLoS One. 2013 Oct 2;8(10):e75431. doi: 10.1371/journal.pone.0075431. eCollection 2013.

24.

Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study.

Askey-Jones S, David AS, Silber E, Shaw P, Chalder T.

Behav Res Ther. 2013 Oct;51(10):648-55. doi: 10.1016/j.brat.2013.04.001. Epub 2013 Apr 25.

PMID:
23916634
25.

Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: a population-based study.

Sleeman KE, Ho YK, Verne J, Glickman M, Silber E, Gao W, Higginson IJ; GUIDE_Care Project.

Palliat Med. 2013 Oct;27(9):840-6. doi: 10.1177/0269216313490436. Epub 2013 Jun 4.

PMID:
23737036
26.

Radar-enabled recovery of the Sutter's Mill meteorite, a carbonaceous chondrite regolith breccia.

Jenniskens P, Fries MD, Yin QZ, Zolensky M, Krot AN, Sandford SA, Sears D, Beauford R, Ebel DS, Friedrich JM, Nagashima K, Wimpenny J, Yamakawa A, Nishiizumi K, Hamajima Y, Caffee MW, Welten KC, Laubenstein M, Davis AM, Simon SB, Heck PR, Young ED, Kohl IE, Thiemens MH, Nunn MH, Mikouchi T, Hagiya K, Ohsumi K, Cahill TA, Lawton JA, Barnes D, Steele A, Rochette P, Verosub KL, Gattacceca J, Cooper G, Glavin DP, Burton AS, Dworkin JP, Elsila JE, Pizzarello S, Ogliore R, Schmitt-Kopplin P, Harir M, Hertkorn N, Verchovsky A, Grady M, Nagao K, Okazaki R, Takechi H, Hiroi T, Smith K, Silber EA, Brown PG, Albers J, Klotz D, Hankey M, Matson R, Fries JA, Walker RJ, Puchtel I, Lee CT, Erdman ME, Eppich GR, Roeske S, Gabelica Z, Lerche M, Nuevo M, Girten B, Worden SP; Sutter’s Mill Meteorite Consortium.

Science. 2012 Dec 21;338(6114):1583-7. doi: 10.1126/science.1227163.

PMID:
23258889
27.

A randomized controlled trial of cognitive behavioral therapy (CBT) for adjusting to multiple sclerosis (the saMS trial): does CBT work and for whom does it work?

Moss-Morris R, Dennison L, Landau S, Yardley L, Silber E, Chalder T.

J Consult Clin Psychol. 2013 Apr;81(2):251-62. doi: 10.1037/a0029132. Epub 2012 Jun 25.

PMID:
22730954
28.

A nurse-led mental health service for people with multiple sclerosis.

Askey-Jones S, Silber E, Shaw P, Gray R, David AS.

J Psychosom Res. 2012 Jun;72(6):463-5. doi: 10.1016/j.jpsychores.2012.01.020. Epub 2012 Mar 30.

PMID:
22656445
29.

The Mental Health Needs of Individuals Living With Multiple Sclerosis: Implications for Occupational Therapy Practice and Research.

Mesa A, Anderson KH, Askey-Jones S, Gray R, Silber E.

Mental Health Spec Interest Sect Q. 2012;35(2):1-4. No abstract available.

30.

Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained.

Higginson IJ, Costantini M, Silber E, Burman R, Edmonds P.

Postgrad Med J. 2011 Nov;87(1033):769-75. doi: 10.1136/postgradmedj-2011-130290. Epub 2011 Oct 6.

PMID:
21978993
31.

Cognitive and behavioural correlates of different domains of psychological adjustment in early-stage multiple sclerosis.

Dennison L, Moss-Morris R, Silber E, Galea I, Chalder T.

J Psychosom Res. 2010 Oct;69(4):353-61. doi: 10.1016/j.jpsychores.2010.04.009. Epub 2010 Jun 9.

PMID:
20846536
32.

Osteoporosis in multiple sclerosis.

Hearn AP, Silber E.

Mult Scler. 2010 Sep;16(9):1031-43. doi: 10.1177/1352458510368985. Epub 2010 Jun 15. Review.

PMID:
20551086
33.

Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service.

Edmonds P, Hart S, Wei Gao, Vivat B, Burman R, Silber E, Higginson IJ.

Mult Scler. 2010 May;16(5):627-36. doi: 10.1177/1352458510364632. Epub 2010 Mar 19.

PMID:
20305044
34.

Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial.

Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM.

J Pain Symptom Manage. 2009 Dec;38(6):816-26. doi: 10.1016/j.jpainsymman.2009.07.002.

PMID:
19833477
35.

Cerebellar ataxia after malaria.

Teo JT, Swayne OB, Silber E.

Neurology. 2009 Jul 7;73(1):73-4. doi: 10.1212/WNL.0b013e3181aae9e6. No abstract available.

PMID:
19564588
36.

Enhancing the mental well-being of people with multiple sclerosis.

Askey-Jones S, Gray R, Shaw P, Chalder T, David A, Gournay K, Silber E.

Nurs Times. 2009 Feb 24-Mar 2;105(7):22. No abstract available.

PMID:
19326649
37.

Drug treatment outcomes for persons on waiting lists.

Chun J, Guydish JR, Silber E, Gleghorn A.

Am J Drug Alcohol Abuse. 2008;34(5):526-33. doi: 10.1080/00952990802146340.

38.

Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up.

Higginson IJ, Hart S, Burman R, Silber E, Saleem T, Edmonds P.

BMC Palliat Care. 2008 May 28;7:7. doi: 10.1186/1472-684X-7-7.

39.

Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative care.

Turner-Stokes L, Sykes N, Silber E; Guideline Development Group.

Clin Med (Lond). 2008 Apr;8(2):186-91.

40.

Neurosarcoidosis presenting as ghost lesions in the CNS: a diagnostic dilemma.

deSouza RM, Crocker M, Wijesekera L, Hampton T, Silber E, Chandler C.

Br J Hosp Med (Lond). 2008 Feb;69(2):108-9. No abstract available.

PMID:
18386743
41.

'Fighting for everything': service experiences of people severely affected by multiple sclerosis.

Edmonds P, Vivat B, Burman R, Silber E, Higginson IJ.

Mult Scler. 2007 Jun;13(5):660-7. Epub 2007 Feb 9.

PMID:
17548447
42.
43.

Loss and change: experiences of people severely affected by multiple sclerosis.

Edmonds P, Vivat B, Burman R, Silber E, Higginson IJ.

Palliat Med. 2007 Mar;21(2):101-7.

PMID:
17344258
44.

Cannabis use in patients with multiple sclerosis.

Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E.

Mult Scler. 2006 Oct;12(5):646-51.

PMID:
17086912
45.

Symptom prevalence and severity in people severely affected by multiple sclerosis.

Higginson IJ, Hart S, Silber E, Burman R, Edmonds P.

J Palliat Care. 2006 Autumn;22(3):158-65.

PMID:
17058754
46.
47.

Sleep and fatigue in multiple sclerosis.

Stanton BR, Barnes F, Silber E.

Mult Scler. 2006 Aug;12(4):481-6.

PMID:
16900762
48.

Osmotic demyelination syndrome.

Abbott R, Silber E, Felber J, Ekpo E.

BMJ. 2005 Oct 8;331(7520):829-30. No abstract available.

49.

Clinical features of headache at altitude: a prospective study.

Silber E, Sonnenberg P, Collier DJ, Pollard AJ, Murdoch DR, Goadsby PJ.

Neurology. 2003 Apr 8;60(7):1167-71.

PMID:
12682326
50.

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.

Eikelenboom MJ, Petzold A, Lazeron RH, Silber E, Sharief M, Thompson EJ, Barkhof F, Giovannoni G, Polman CH, Uitdehaag BM.

Neurology. 2003 Jan 28;60(2):219-23.

PMID:
12552034

Supplemental Content

Loading ...
Support Center